This is in accordance with previous reports demonstrating that perturbed TGF-β signaling induces endothelial-mesenchymal transition enhancing fibrosis and non-hereditary disorders such as atherosclerosis and cardiac fibrosis (Pardali et al., 2017; Goumans and Ten Dijke, 2018). This evidence concerns the gene TGFB1 and atherosclerosis.